Two weeks after the pharmaceutical industry predicted dire consequences for innovation if the prescription price reduction plan proposed by House Speaker Nancy Pelosi passes, the White House is now echoing those concerns but suggesting even worse outcomes than industry analysts predict.
Original Article: White House Claims Pelosi Plan Would Cause Loss of 100 New Drugs Over 10 Years
NEXT ARTICLEQuick Links
Advanced Search |
Login |
Subscribe |
RSS